These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 732257)

  • 21. Effects of central and peripheral angiotensin blockade in hypertensive rats.
    Mann JF; Phillips MI; Dietz R; Haebara H; Ganten D
    Am J Physiol; 1978 May; 234(5):H629-37. PubMed ID: 645931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immediate pressor effect of saralasin in man.
    Carey RM; Vaughan ED; Ackerly JA; Peach MJ; Ayers CR
    J Clin Endocrinol Metab; 1978 Jan; 46(1):36-43. PubMed ID: 752023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of adrenergic mediation of agonist response to [Sar1,Ala8]angiotensin II in conscious normotensive and hypertensive dogs.
    Zimmerman BG
    Clin Sci (Lond); 1979 Jul; 57(1):71-81. PubMed ID: 38941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
    Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
    McGrath BP; Ledingham JG; Benedict CR
    Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
    Mimran A; Deschodt G; Shaldon S; Barjon P; Mion C
    Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiotensin II blockade by saralasin in normal man.
    Noth RH; Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.
    Leonetti G; Terzoli L; Sala C; Bianchini C; Sernesi L; Zanchetti A
    Clin Sci Mol Med Suppl; 1978 Dec; 4():307s-309s. PubMed ID: 282074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats.
    Hutchinson JS; Mendelsohn FA; Doyle AE
    Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M; Fiorentini R; Onesti G; Bellini G; Gould AB; Hessan H; Kim KE; Swartz C
    Clin Sci Mol Med; 1978 Jun; 54(6):633-7. PubMed ID: 657733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
    MacGregor GA; Dawes PM
    Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus.
    Broughton Pipkin F; O'Brien PM
    Am J Obstet Gynecol; 1978 Sep; 132(1):7-15. PubMed ID: 696788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral and neurogenic factors in two-kidney renovascular hypertension.
    de la Riva IJ; Basso N; Kurnjek ML; Taquini AC
    Arch Int Physiol Biochim; 1980 May; 88(2):137-46. PubMed ID: 6159837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R; Lijnen P; Amery A; Reybrouck T
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.